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Background
Patients are increasingly involved in design and imple-
mentation of clinical studies. Despite checklists for
reporting patient involvement, and increasing focus on
the impact of patient involvement, evaluations remain
scarce. We evaluated impact of patient involvement in
an NIHR supported research programme focusing on
joint replacement: ‘RESTORE’.
Context
The RESTORE programme comprises a randomised
controlled trial, three pilot trials, a cohort study, qualita-
tive studies and systematic reviews. Since 2010, the
patient panel (PEP-R), has inputted into RESTORE.
Seventeen patients have been involved in total, 8 were
recruited at the time of the evaluation. Through facili-
tated group sessions, PEP-R provides input into refine-
ment of patient recruitment materials, intervention
development, readability of outcome assessment tools,
and dissemination of findings. Patients also sit on steer-
ing groups and receive training.
Methods
Impact of patient involvement was evaluated through
questionnaires completed by patients and research staff.
All participants were asked to identify the impact of
PEP-R on themselves and the research. Eight patients
and 14 researchers completed the questionnaire.
Responses were analysed using qualitative ‘framework’
approach.
Results
Patients described their interest in learning about
research. They valued feedback about how PEP-R’s
input had shaped studies. Researchers identified the
benefits of obtaining patients’ views on the importance,
relevance and feasibility of their projects. They wel-
comed the opportunity to speak to an interested and
knowledgeable group and stressed the importance of
early involvement.
Conclusion
Patients and researchers see patient involvement as
beneficial. The model used in PEP-R facilitates patient
involvement in the design and implementation of clini-
cal research.
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